Huadong Medicine Co., Ltd (SHE:000963)
China · Delayed Price · Currency is CNY 28.72
+2.31 (8.75%)
Jun 29, 2026, 3:04 PM CST
Huadong Medicine Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Huadong Medicine stock has a consensus rating of "Buy" and an average price target of ¥47.12. The average 1-year stock price forecast is 64.07% higher than the current stock price, while the lowest is ¥39.00 (+35.79%) and the highest is ¥57.00 (+98.47%).
Price Target: ¥47.12 (+64.07%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Huadong Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 10 | 10 | 10 | 9 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 15 | 15 | 14 | 13 | 13 | 12 |
Financial Forecast
Revenue This Year
46.57B
from 43.61B
Increased by 6.79%
Revenue Next Year
49.11B
from 46.57B
Increased by 5.44%
EPS This Year
2.24
from 1.89
Increased by 18.49%
EPS Next Year
2.52
from 2.24
Increased by 12.33%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 49.3B | ||
| Avg | 46.6B | ||
| Low | 45.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.9% | ||
| Avg | 6.8% | ||
| Low | 3.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.24 | ||
| Avg | 2.24 | ||
| Low | 2.24 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.5% | ||
| Avg | 18.5% | ||
| Low | 18.5% |